Eli Lilly plans to submit retatrutide for FDA approval in Q1 2027 across three indications. This timeline, clinical efficacy data, and regulatory classification disputes carry implications for research access, gray-market demand, and approval probability.
Retatrutide remains investigational in 2026, but Eli Lilly's expanded access program offers a legal pathway for severely affected patients. This guide clarifies eligibility criteria, safety data, and the regulatory distinction between FDA-authorized compassionate use and illicit research-chemical markets.
Eli Lilly filed six lawsuits in August 2026 against vendors selling unapproved retatrutide, signaling intensified FDA enforcement against illicit gray-market peptide sales. This article clarifies the regulatory distinction between legal research-use compounds and unlicensed commercial distribution.
Research-grade peptides require rigorous analytical verification—HPLC purity, LC-MS/MS identity confirmation, and endotoxin testing—to distinguish genuine compounds from marketing claims. Understanding Certificates of Analysis and quality standards is essential for researchers evaluating peptide suppliers.
Researchers evaluating US-based peptide suppliers need objective analytical documentation standards to distinguish genuine manufacturers from repackagers. This practical verification checklist translates quality standards into a reproducible protocol.
Distinguishing genuine US-manufactured peptides from marketing claims requires systematic verification of synthesis location, testing independence, and batch-specific documentation. This guide outlines the critical questions researchers should ask suppliers to confirm authenticity.
Comprehensive guide to designing reproducible MK-677 research protocols, including GHS-R1a mechanism, biomarker monitoring timelines, and outcome measurement strategies for legitimate laboratory investigation.
Researchers face a critical verification gap: distinguishing genuine US-manufactured peptides from resellers using marketing language. This guide provides actionable steps to validate synthesis location, Certificate of Analysis authenticity, and third-party testing standards.
A practical guide to evaluating peptide Certificates of Analysis, verifying laboratory independence, and interpreting HPLC and mass spectrometry results to confirm compound identity and purity.